生物标志物 生物标志物
Gemma Salvadó1,2, Kanta Horie3,4,5,6, Nicolas R Barthélemy6,7
1Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
一个新的阿尔茨海默病 (AD) 阶段测定系统使用了血%p-tau217和eMTBR-tau243生物标志物. 这种非侵入性方法准确地分阶段AD进展,提供一个可扩展的替代PET扫描.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 对生物阿尔茨海默病 (AD) 的准确分期对于临床试验和治疗开发至关重要.
- 目前的血生物标志物缺乏针对晚期AD阶段的特异性.
- 这项研究引入了一种新的分期方法,使用两个高性能等离子体生物标志物:%p-tau217和eMTBR-tau243.
研究的目的:
- 开发和验证一种可扩展,低侵入性的方法,用于阿尔茨海默病 (AD) 的生物分期.
- 评估血%p-tau217和eMTBR-tau243在反映AD病理和进展方面的有用性.
主要方法:
- 包括来自BioFINDER-2研究的764人,覆盖了AD连续.
- 使用质谱法测量了血%p-tau217和eMTBR-tau243水平.
- 结合生物标志物系统被用来定义五个基于血的AD阶段 (阶段-0到阶段-5),与PET成像和认知测量相比.
主要成果:
- 在eMTBR-tau243之前,血%p-tau217水平增加,这表明了序列生物标志物的动态.
- 较高的血生物标志物阶段与异常的粉样β和蛋白PET成像以及认知衰退有显著的相关性.
- 基于等离子体的分期系统在预测基于PET和临床AD阶段方面表现出高准确性.
结论:
- 血%p-tau217和eMTBR-tau243的组合可以准确地确定阿尔茨海默病的生物学阶段.
- 这种基于等离子体的方法是非侵入性的,可扩展的,并为基于CSF或PET的分期提供了切实可行的替代方案.
- 这种方法有助于改善临床试验和疾病管理的患者分层.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516